Life Science Product News

During a Bio-Rad workshop at PMWC, panelists will discuss how Droplet Digital PCR helps physicians monitor immunotherapy effectiveness in patients.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company has been awarded a contract for iQ-Check real-time PCR pathogen detection test kits and the iQ-Check Prep Automation System from the United States Department of Agriculture’s Food Safety and Inspection Service (USDA FSIS).

Research from NYU Langone Medical Center and its Perlmutter Cancer Center along with Bio-Rad’s Digital Biology Group demonstrates how two new ddPCR-based assays can specifically detect and quantify mutations linked to many cancer types.

The scATAC-Seq solution allows researchers to gain a deeper understanding about the mechanisms of cell fate, identify the cell types present in heterogeneous tissues, and validate single-cell gene expression data.

Bio-Rad Laboratories, Inc. announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

In clinical trials, researchers are increasingly turning to Droplet Digital PCR to measure cell-free tumor DNA as a biomarker of treatment response.

Bio-Rad's RAPID chromogenic media and MALDI Biotyper® from Bruker are used together by labs to detect the presence of pathogens in food and confirm/identify the organism.

StarBright Blue 520 Fluorescent Secondary Antibodies offer highly sensitive fluorescent detection and multiplexing for detecting up to three unique proteins on a western blot.

The Bio-Plex Pro Human Cytokine Screening Panel is a multiplex assay that can accurately and reproducibly quantify up to 48 analytes involved in complex biological networks in a single assay.

A number of studies powered by ddPCR exploring epigenetics and immunotherapy will be presented at this year’s AACR meeting.